Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

about

MicroRNAs as Biomarkers in Thyroid Carcinoma.Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib.Dermal Hyperneury and Multiple Sclerotic Fibromas in Multiple Endocrine Neoplasia Type 2A Syndrome.

P2860

Q42361202-DACBC2A1-FF0F-4B9D-AD0E-2AEEAF5BA7B7 Q47395532-FE94D3E3-66C9-4182-86F8-30CEA71029D9 Q47628801-7BBAEB06-F0CC-4127-A52A-75B2D32A1FB4

P2860

Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

Item

http://www.wikidata.org/entity/Q38931460

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

@en

type

Item

label

Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

@en

prefLabel

Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

@en

P1476

Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression

@en

P2093

Ricardo V Lloyd

http://www.w3.org/2001/XMLSchema#string

P2860

Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system

Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis

RAS proto-oncogene in medullary thyroid carcinoma

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

Biological relevance of medullary thyroid microcarcinoma.

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.

P2888

s12022-016-9449-0

P304

312-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12022-016-9449-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ying-Hsia Chu

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000671308

http://www.w3.org/2001/XMLSchema#string

P698

27539727

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression

Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

about

P2860

P2860

Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921